Pasithea Therapeutics Corp. (KTTA) stock
KTTANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.51+0.08 (+17.64%)
Close on Nov 18, 2026Market cap $17.07MP/E –Yield –
Pasithea Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Pasithea Therapeutics's total assets was $51.71M at Jun 30, 2026. For fiscal 2025 it was $60.24M, up 275.0% from the year before. The highest annual figure on record is $60.24M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $60.24M | +275.0% |
| FY2024 | Dec 31, 2024 | $16.06M | -38.5% |
| FY2023 | Dec 31, 2023 | $26.12M | -42.2% |
| FY2022 | Dec 31, 2022 | $45.18M | -15.3% |
| FY2021 | Dec 31, 2021 | $53.32M | +21403.9% |
| FY2020 | Dec 31, 2020 | $247.96K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $51.71M | +204.0% |
| Q1 FY2026 | Mar 31, 2026 | $56.35M | +284.4% |
| Q4 FY2025 | Dec 31, 2025 | $60.24M | +275.0% |
| Q3 FY2025 | Sep 30, 2025 | $13.63M | -26.9% |
| Q2 FY2025 | Jun 30, 2025 | $17.01M | -3.7% |
| Q1 FY2025 | Mar 31, 2025 | $14.66M | -34.6% |
| Q4 FY2024 | Dec 31, 2024 | $16.06M | -38.5% |
| Q3 FY2024 | Sep 30, 2024 | $18.64M | -39.2% |
| Q2 FY2024 | Jun 30, 2024 | $17.66M | -53.7% |
| Q1 FY2024 | Mar 31, 2024 | $22.41M | -46.7% |
| Q4 FY2023 | Dec 31, 2023 | $26.12M | -42.2% |
| Q3 FY2023 | Sep 30, 2023 | $30.66M | -38.2% |
| Q2 FY2023 | Jun 30, 2023 | $38.15M | -28.1% |
| Q1 FY2023 | Mar 31, 2023 | $42.04M | -17.7% |
| Q4 FY2022 | Dec 31, 2022 | $45.18M | -15.3% |
| Q3 FY2022 | Sep 30, 2022 | $49.61M | +135.8% |
| Q2 FY2022 | Jun 30, 2022 | $53.03M | +21285.8% |
| Q1 FY2022 | Mar 31, 2022 | $51.08M | – |
| Q4 FY2021 | Dec 31, 2021 | $53.32M | – |
| Q3 FY2021 | Sep 30, 2021 | $21.04M | – |
| Q4 FY2020 | Dec 31, 2020 | $247.96K | – |
See a number that looks wrong?